PDF(186 KB) - jifsan
PDF(186 KB) - jifsan
PDF(186 KB) - jifsan
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Working Group 5 – Risk Communication<br />
“There’s a kind of hush all over the world, but . .<br />
we need to be prepared on all fronts”<br />
This statement characterizes the current climate of media response to acrylamide as<br />
evidenced by the IFIC media-monitoring chart below:<br />
Number of<br />
Articles<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Jan-Mar<br />
02<br />
Turnquist presentation in Sweden<br />
Apr-Jun<br />
02<br />
Jul-Sep<br />
02<br />
Oct-Dec<br />
02<br />
FDA Data<br />
Jan-Mar<br />
03<br />
Apr-Jun<br />
03<br />
Intl Research and<br />
Prop 65<br />
Jul-Sep<br />
03<br />
Oct-Dec<br />
03<br />
ACS mtg, FDA<br />
data Harvard study<br />
Jan-Mar<br />
04<br />
Recommendations from Working Group 5 include:<br />
‣ Develop and distribute transparent meeting summary to interested parties on a<br />
timely basis<br />
‣ Ongoing monitoring of this issue will help avoid surprises<br />
‣ Characterize the global (research and international collaboration) effort that has<br />
been put forth thus far and how it is likely to continue beyond the acrylamide<br />
issue. This will help reassure the public of a credible research agenda; such<br />
patience will yield solid scientific results.<br />
June 2004<br />
JIFSAN Acrylamide Workshop: Summary of Working Group 5 – Risk Communication 4
Change language